Please assess the completion status of the following clinical trial:

Trial Title: An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Current cigarette smokers between the ages of 18 and 75 years, who are motivated to stop smoking~Exclusion Criteria:~* Patients currently suffering from depression, or have been diagnosed with depression in the last 12 months, or subjects with past or present history of psychosis, panic disorder, or bipolar disorder~* Any subject with known severe chronic obstructive pulmonary disease (COPD)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).